Coronavirus Vaccine – Pfizer and BioNTech’s vaccine was announced to be more than 90 percent effective against the virus.

In experiments with a large group of subjects, the coronavirus vaccine developed by Pfizer and BioNTech was announced to be “more than 90 percent effective” against Covid-19 disease. Pfizer and BioNTech announced the development with the words “a great day for science and humanity.”

The candidate vaccine in question was tested in 43,500 people in 6 countries. No serious safety issues arose in the trials.

Among the countries where the coronavirus vaccine has also called Turkey.

Vaccine manufacturing companies are reportedly planning to apply for emergency use approval later this month.

The vaccine will be given in two doses, three weeks apart. Pfizer plans to launch 50 million doses of vaccines by the end of the year and 1.3 billion doses by the end of 2021.

Pfizer CEO Albert Bourla said he wanted to be among the first vaccines to allay public concerns about the safety of the vaccine, but added that ethical barriers could arise.

Speaking to CNBC, Bourla said: “If we have a limited dose of vaccine, I’m not sure people will approve of people my age and ability being included in the first group of vaccines. So I would like to respect that.

Pfizer shares soared in previous transactions ahead of the US market opening, after the successful testing of the third stage of the vaccine was announced. Later, it gained 17 percent in value.

The founders of the German company Biontech, a family of children who have migrated from Turkey to Germany eager for Türeci and also the CEO of the company, Ugur Sahin.

Uğur Şahin said his results were a “turning point”.

Christian Odandahl, chief economist at the European Reform Center, tweeted: “Germany has long struggled with how open immigration should be, and the postwar ‘guest worker’ program has always been questioned. Uğur Şahin’s father was one of these guest workers who came to work at the Ford factory in Cologne “Now your son can be the one to end the epidemic around the world.”

The speed at which vaccine manufacturers will respond to your request for emergency use approval later this month will determine when use of the vaccine will begin.

Around the world, vaccination is seen as the most effective way to end pandemic measures that limit people’s lives, along with more advanced treatments.

There are currently more than 10 candidate vaccines in different parts of the world, whose final trials known as “stage three” are underway. But Pfizer and BioNTech were the first to conclude.

A purely experimental approach was adopted. Part of the partial genetic sequence of the virus is injected into the body to train the immune system against the virus.

In previous trials, it was revealed that the vaccine causes the body to produce cells that are part of the immune system called antibodies and T cells. Two doses of the vaccine should be given three weeks apart.

Trials from the US, Germany, Brazil, Argentina, South Africa, and Turkey continued and revealed a second dose of the vaccine 7 days after it provides 90 percent protection against coronaviruses.

Britain had ordered 10 million doses before trials were completed by the end of the year, and already 30 million doses by next year. However, some logistical problems can arise due to the need to keep the vaccine at minus 80 degrees Celsius.

“Good news,” said US President Donald Trump of the statement from Pfizer and BioNTech.

Joe Biden, who was elected the 46th president of the US, said that the Covid-19 vaccine gives hope, but there is still a long fight ahead.

After the announcement that the coronavirus vaccine developed by Pfizer and BioNTech was “more than 90 percent effective” against Covid-19 disease, there was a surge in global markets. US Treasuries fell and the dollar weakened against major currencies, Bloomberg HT reported. Investors entered risky assets after the announcement. Safe assets have been sold.

S&P 500 index futures were up 3.6 percent. Contracts in the Russell 2000 index were up 7 percent. Although the technology-weighted Nasdaq 100 index declines, it is at 0.8 percent.

With the news, there was also a sharp rise in crude prices. The price per barrel rose to $ 39.94, and the most recent WTI oil contracts saw an increase of more than 7 percent. Brent oil, meanwhile, reached 7 percent and was quoted at 42.16 dollars a barrel.

Following the vaccine news from Pfizer, the increase in the BIST transport index also exceeded 6 percent. Following the intense flow of news over the weekend, the BIST 100 index had already started the new week with a rapid rise. The index, which gained 2.10 percent value at the open, hit its highest level in 9 months later in the session.